|
|
||||||||
J Thorac Cardiovasc Surg 2008;135:938-944
© 2008 The American Association for Thoracic Surgery
Cardiothoracic Transplantation |
Heart Transplant Program, Peter Munk Cardiac Center, Toronto General Hospital; Division of Cardiac Surgery, University of Toronto; and Division of Cardiology, University of Toronto, Toronto, Ontario, Canada
Received for publication May 14, 2007; revisions received August 18, 2007; accepted for publication September 6, 2007. * Address for reprints: Vivek Rao, MD, PhD, Toronto General Hospital, Division of Cardiovascular Surgery, 4N-464, 200 Elizabeth Street, Toronto, Ontario, Canada M5G 2C4. (Email: vivek.rao{at}uhn.on.ca).
Objective: Cyclosporine A and corticosteroids are associated with many side effects, such as endothelial dysfunction and transplant vasculopathy. We examined the effects of cyclosporine A and hydrocortisone exposure on endothelial function of the rat thoracic aorta.
Methods: Lewis rats were injected with cyclosporine A, hydrocortisone, cyclosporine A + hydrocortisone, or intraperitoneal saline daily for 2 weeks. Endothelial-dependent and independent vascular relaxation were assessed in isolated segments of thoracic aorta, as well as endothelin-1–induced vasoreactivity. Protein expression of endothelial nitric oxide synthase, endothelinA, and endothelinB receptors were also determined in the thoracic aorta.
Results: Exposure to cyclosporine A and cyclosporine A + hydrocortisone resulted in a reduction in endothelial-dependent vasorelaxation compared with control and hydrocortisone (P = .001). Cyclosporine A and hydrocortisone-treated rats demonstrated increased vasoreactivity to endothelin-1 compared with control, whereas cyclosporine A + hydrocortisone treatment resulted in a synergistic increase (P = .04). All treatment groups displayed a significant reduction in endothelial nitric oxide synthase expression compared with control (P = .001). EndothelinA receptor expression was increased in all treatment groups with a synergistic effect seen after cyclosporine A + hydrocortisone treatment. No differences were seen in endothelinB receptor expression.
Conclusion: Cyclosporine A and hydrocortisone induce vasomotor dysfunction with a synergistic impairment observed after concomitant exposure. Our findings suggest that the resultant vasomotor dysfunction is the result of alterations in both nitric oxide and endothelin-1 regulation.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |